1Thompson JS, Thacker LR. CREG Matching for first cadaveric kidney transplants(TNX) performed by SEOPE centers between 1987 and 1995. Clin Transplant1996, 10(6 Pt 2): 586-593. 被引量：1
2Lorranine C, Kim S, Robert B, et al. The Banff97 working classification of renal allograft pathology. Kidney Int 1999, 55(2): 713-723. 被引量：1
3Sumitarr Holgersson S. HLA-specific alloantibodies and renal graft outcome. Nephrol Dial Transplant 2001, 16(5): 897-904. 被引量：1
4Christopher S, Robert S, Woodward S, et al. The economic benefit of allocation of kidmeys based on cross-reactive group matching. Transplantation 2000, 70(3): 537-540. 被引量：1
5Supkens WWJ, Doxiadis IN, de Fijter JW, et al. Shareing cross-reactive groups of MHC class I improves lomg-term graft survival. Kidney Int 1999, 56(5): 1920-1927. 被引量：1
9Pzepiorka D, Keman NA, Ippoliti C, et al. Daclizumab, a humanized antrinterleukin-2 receptor alpha chain antibody,for treatment of acute graft-versus-host disease. Am Soc Hemato12000, 95(1): 83-87. 被引量：1
10Abou-Jaoude MM, Ghantous I, Almawi WY, et al. Comparison of daclizumab, an interletfldn 2 receptor antibody, to anti-lhymocyte globulin-Fresenius induction therapy in kidney transplantation. Mol Immunol 2003, 39(17-18): 1083-1088. 被引量：1
